Table 2.
Characteristics of the horizontally HIV-infected group at enrolment (N = 85)
| Gender–No. (%) | |
| Female | 46 (54.1) |
| Mode of HIV acquisition—No. (%) | |
| Blood product transfusion | 19 (22.4) |
| Consensual sexual contact | 32 (37.6) |
| No known risk factors | 31 (36.5) |
| Other | 1 (1.2) |
| Sexual abuse | 1 (1.2) |
| Unknown | 1 (1.2) |
| CD4% at enrolment—No. (%) | |
| <15% | 12 (15.6) |
| 15–24% | 20 (26.0) |
| ≥25% | 45 (58.4) |
| Missinga | 8 |
| HIV RNA copies/ml at enrolment—No. (%) | |
| <500 | 29 (35.4) |
| 500–9999 | 24 (29.3) |
| 10 000–99 999 | 28 (34.1) |
| ≥100 000 | 1 (1.2) |
| Missinga | 3 |
| Type of ARV regimen received at enrolment—No. (%) | |
| No ARV | 30 (35.3) |
| NRTI-based only | 7 (8.2) |
| PI-based HAART | 27 (31.8) |
| NNRTI-based HAART | 16 (18.8) |
| PI + NNRTI-based HAART | 5 (5.9) |
aNot included in % calculation.